Skip to main content

Inari Medical, Inc.

NARIDelisted Feb 19, 2025
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001531048

Inari Medical, Inc. was delisted on Feb 19, 2025; its insiders filed their last Form 4 on Feb 19, 2025; 258 institutions reported holding it in 13F filings for Q4 2024, worth $2.80B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Inari Medical, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Inari Medical, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Inari Medical, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Mead Dana G Jr.Director0Feb 19, 20250
Root Jonathan DDirector0IndirectFeb 19, 20250
Milder Donald BDirector0IndirectFeb 19, 20250
Hoffman WilliamDirector0Feb 19, 20250
Lucchese Cynthia LDirector0Feb 19, 20250
Szyman Catherine M.Director0Feb 19, 20250
Tu ThomasChief Medical Officer0Feb 19, 20250
Hykes AndrewPresident and CEO0Feb 19, 20250
Chambers RebeccaDirector0Feb 19, 20250
Warner Robert KeithDirector0Feb 19, 20250
Strange Kevin TChief Financial Officer0Feb 19, 20250
Silva KarenPrincipal Accounting Officer0Feb 19, 20250
Hill, Mitch C.Chief Financial Officer177,533Oct 2, 20240
Nielsen Kirk G.Director61,479May 30, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 14, 2023 (view filing)4:35 PM ETJul 122 daysHill, Mitch C.Chief Financial OfficerSSale−6.50K$56.24−$365.5K−3.7%171.5K after2 lots10b5-1
Jun 16, 2023 (view filing)Jun 151 dayHoffman WilliamDirectorSSale−25.0K$57.74−$1.44M−2.2%1.10M after4 lots10b5-1
Jun 13, 2023 (view filing)5:48 PM ETJun 121 dayHill, Mitch C.Chief Financial OfficerSSale−6.50K$59.24−$385.1K−3.6%173.1K after2 lots10b5-1
May 18, 2023 (view filing)May 15-173 daysLateHoffman WilliamDirectorSSale−106.9K$70.13−$7.50M−8.7%1.12M after12 lots10b5-1
May 18, 2023 (view filing)May 16-172 daysHykes AndrewPresident and CEOSSale−36.7K$70.01−$2.57M−6.7%513.6K after6 lots
May 18, 2023 (view filing)May 16-172 daysTu ThomasChief Medical OfficerSSale−24.9K$70.01−$1.75M−6.3%373.7K after6 lots
May 16, 2023 (view filing)5:41 PM ETMay 124 daysHill, Mitch C.Chief Financial OfficerSSale−12.8K$70.26−$895.8K−6.9%173.1K after4 lots10b5-1
Apr 19, 2023 (view filing)Apr 172 daysHoffman WilliamDirectorSSale−25.0K$64.67−$1.62M−2.0%1.23M after4 lots10b5-1
Apr 14, 2023 (view filing)4:44 PM ETApr 122 daysHill, Mitch C.Chief Financial OfficerSSale−12.8K$64.27−$819.4K−6.6%179.3K after8 lots10b5-1
Mar 21, 2023 (view filing)Mar 201 dayHykes AndrewPresident and CEOSSale−9.00K$64.29−$578.6K−1.6%552.3K after2 lots
Mar 17, 2023 (view filing)4:53 PM ETMar 152 daysHoffman WilliamDirectorSSale−25.0K$63.23−$1.58M−2.0%1.25M after6 lots
Mar 14, 2023 (view filing)7:05 PM ETMar 131 dayHill, Mitch C.Chief Financial OfficerSSale−12.8K$58.63−$747.6K−6.4%187.0K after6 lots
Mar 14, 2023 (view filing)Mar 14Same dayHoffman WilliamDirectorSSale−5.00K$60.10−$300.5K−0.4%1.25M after
Mar 1, 2023 (view filing)6:13 PM ETFeb 272 daysTu ThomasChief Medical OfficerSSale−10.0K$56.72−$567.2K−8.5%107.1K after2 lots
Feb 22, 2023 (view filing)Feb 211 dayHykes AndrewPresident and CEOSSale−9.00K$55.19−$496.7K−6.4%130.6K after
Feb 17, 2023 (view filing)Feb 152 daysHoffman WilliamDirectorSSale−50.0K$58.59−$2.93M−14.4%296.2K after9 lots
Feb 15, 2023 (view filing)4:43 PM ETFeb 132 daysHill, Mitch C.Chief Financial OfficerSSale−12.8K$53.82−$686.1K−21.5%46.5K after4 lots
Jan 31, 2023 (view filing)4:28 PM ETJan 274 daysTu ThomasChief Medical OfficerSSale−10.0K$60.69−$606.9K−10.4%85.7K after6 lots
Jan 24, 2023 (view filing)Jan 204 daysHykes AndrewPresident and CEOSSale−9.00K$61.90−$557.1K−8.8%93.0K after3 lots
Jan 19, 2023 (view filing)Jan 172 daysHoffman WilliamDirectorSSale−55.0K$66.90−$3.68M−13.7%345.9K after14 lots
Jan 13, 2023 (view filing)4:50 PM ETJan 121 dayHill, Mitch C.Chief Financial OfficerSSale−12.8K$66.04−$842.0K−19.6%52.5K after5 lots
Dec 28, 2022 (view filing)4:32 PM ETDec 271 dayTu ThomasChief Medical OfficerSSale−10.0K$63.29−$632.9K−10.4%86.5K after4 lots
Dec 22, 2022 (view filing)Dec 202 daysHykes AndrewChief Operating OfficerSSale−9.00K$68.50−$616.5K−8.0%103.0K after3 lots
Dec 16, 2022 (view filing)5:37 PM ETDec 151 dayHoffman WilliamPresident and CEOSSale−55.0K$66.61−$3.66M−18.8%237.5K after9 lots
Dec 14, 2022 (view filing)4:22 PM ETDec 122 daysHill, Mitch C.Chief Financial OfficerSSale−12.8K$69.58−$887.1K−17.7%59.5K after4 lots
Nov 30, 2022 (view filing)Nov 282 daysTu ThomasChief Medical OfficerSSale−10.0K$74.86−$748.6K−10.4%86.5K after2 lots
Nov 22, 2022 (view filing)Nov 211 dayHykes AndrewChief Operating OfficerSSale−9.00K$77.66−$698.9K−7.4%112.0K after2 lots
Nov 16, 2022 (view filing)4:38 PM ETNov 142 daysHill, Mitch C.Chief Financial OfficerSSale−12.8K$79.13−$1.01M−16.2%65.7K after6 lots
Nov 16, 2022 (view filing)Nov 151 dayHoffman WilliamPresident and CEOSSale−55.0K$81.67−$4.49M−18.8%237.5K after14 lots
Nov 16, 2022 (view filing)Nov 151 dayMilder Donald BDirectorSSale−7.00K$80.13−$560.9K−0.2%3.19M after
Oct 28, 2022 (view filing)Oct 271 dayTu ThomasChief Medical OfficerSSale−10.0K$75.02−$750.2K−9.4%96.5K after4 lots
Oct 24, 2022 (view filing)Oct 204 daysHykes AndrewChief Operating OfficerSSale−9.00K$72.33−$651.0K−6.9%121.0K after4 lots
Oct 19, 2022 (view filing)Oct 181 dayMilder Donald BDirectorSSale−7.00K$80.07−$560.5K−0.2%3.19M after
Oct 19, 2022 (view filing)Oct 172 daysHoffman WilliamPresident and CEOSSale−55.0K$76.05−$4.18M−15.8%292.5K after14 lots
Oct 17, 2022 (view filing)4:37 PM ETOct 143 daysHill, Mitch C.Chief Financial OfficerSSale−12.8K$73.77−$940.6K−15.0%72.0K after10 lots
Sep 16, 2022 (view filing)Sep 151 dayMilder Donald BDirectorSSale−7.00K$80.25−$561.8K−0.2%3.20M after
Sep 12, 2022 (view filing)Sep 93 daysHoffman WilliamPresident and CEOSSale−13.7K$77.01−$1.05M−3.8%348.9K after3 lots
Sep 9, 2022 (view filing)4:48 PM ETSep 7-82 daysHoffman WilliamPresident and CEOSSale−46.3K$72.75−$3.37M−11.3%362.6K after5 lots
Sep 8, 2022 (view filing)Sep 62 daysHykes AndrewChief Operating OfficerSSale−5.00K$70.00−$350.0K−3.7%131.0K after
Aug 17, 2022 (view filing)4:30 PM ETAug 152 daysHill, Mitch C.Chief Financial OfficerSSale−7.50K$82.30−$617.3K−8.7%78.9K after4 lots
Aug 17, 2022 (view filing)Aug 152 daysMilder Donald BDirectorSSale−7.00K$80.78−$565.5K−0.2%3.21M after3 lots
Aug 9, 2022 (view filing)4:31 PM ETAug 54 daysHoffman WilliamPresident and CEOSSale−30.0K$82.97−$2.49M−5.5%518.9K after5 lots
Aug 4, 2022 (view filing)Aug 22 daysMilder Donald BDirectorSSale−21.0K$80.44−$1.69M−0.6%3.42M after6 lots
Aug 3, 2022 (view filing)Aug 12 daysHykes AndrewChief Operating OfficerSSale−5.00K$78.67−$393.4K−3.5%136.0K after4 lots
Jul 20, 2022 (view filing)Jul 182 daysHoffman WilliamPresident and CEOSSale−5.28K$75.29−$397.2K−1.0%518.9K after
Jul 19, 2022 (view filing)4:35 PM ETJul 154 daysHill, Mitch C.Chief Financial OfficerSSale−7.50K$73.23−$549.2K−8.7%78.9K after3 lots
Jul 12, 2022 (view filing)Jul 84 daysHoffman WilliamPresident and CEOSSale−11.2K$75.17−$844.7K−2.1%524.2K after2 lots
Jul 8, 2022 (view filing)4:39 PM ETJul 6-72 daysHoffman WilliamPresident and CEOSSale−43.5K$72.95−$3.17M−7.5%535.4K after4 lots
Jul 6, 2022 (view filing)Jul 51 dayHykes AndrewChief Operating OfficerSSale−5.00K$70.31−$351.6K−3.4%141.0K after
Jun 17, 2022 (view filing)4:31 PM ETJun 152 daysHill, Mitch C.Chief Financial OfficerSSale−7.50K$60.47−$453.5K−8.6%79.6K after4 lots